Solidarity Wealth LLC Has $4.62 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Solidarity Wealth LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 21.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,899 shares of the healthcare conglomerate’s stock after selling 2,168 shares during the quarter. UnitedHealth Group comprises about 1.3% of Solidarity Wealth LLC’s portfolio, making the stock its 27th biggest holding. Solidarity Wealth LLC’s holdings in UnitedHealth Group were worth $4,618,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC grew its position in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Swedbank AB bought a new position in UnitedHealth Group during the 1st quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group in the second quarter valued at about $480,903,000. Finally, Dimensional Fund Advisors LP increased its holdings in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock opened at $563.71 on Thursday. The company has a market cap of $520.54 billion, a P/E ratio of 36.72, a PEG ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a 50 day simple moving average of $582.60 and a two-hundred day simple moving average of $540.48.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the business earned $6.56 earnings per share. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on UNH. Barclays decreased their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.